Birzeit Pharmaceutical
Birzeit Pharmaceutical is a publicly traded Palestinian manufacturer of generic medicines and pharmaceuticals, founded in 1937 and headquartered in Ramallah. It serves the Palestinian healthcare market and is listed on the Palestine Exchange (PEX:BPC) with 251-500 employees.
- Company typePrivate
- Founded1937
- HeadquartersRamallah
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
What Birzeit Pharmaceutical does
Birzeit Pharmaceutical is a publicly traded Palestinian manufacturer of generic medicines and pharmaceuticals, headquartered in Ramallah. Founded in 1937, the company is one of the longest-operating pharmaceutical manufacturers in the Palestinian market, currently employing between 251 and 500 people. Birzeit Pharmaceutical is listed on the Palestine Exchange (PEX) under the ticker symbol BPC, making it a publicly traded for-profit entity in the regional pharmaceutical sector.
The company operates as a generic pharmaceutical manufacturer, producing medicines likely intended for the Palestinian healthcare market and potentially surrounding regional markets. Its business model is rooted in the production and distribution of generic drug formulations, a segment that typically targets price-sensitive healthcare systems and consumers. However, the available source data is severely limited — the company's primary website (bpc.ps) was inaccessible (returning only a verification/loading page), and no detailed product portfolio, technology stack, distribution channels, pricing models, or financial metrics are present in the available data.
The absence of detailed disclosures on products, partnerships, certifications, management team, subsidiaries, and operational geography reflects a significant transparency gap for a publicly traded entity. This data gap limits rigorous analysis of competitive positioning, revenue mechanics, customer base, and growth trajectory. The firm's 87-year operating history and public listing status suggest a durable, established business, but the lack of substantive financial and operational data prevents deeper strategic assessment.
Birzeit Pharmaceutical firmographics
Firmographics- Name
- Birzeit Pharmaceutical
- Website
- https://bpc.ps
- Company type
- Private
- Founded year
- 1937
- Headcount range
- 251–500 employees
- Short description
- Birzeit Pharmaceutical is a publicly traded Palestinian manufacturer of generic medicines and pharmaceuticals, founded in 1937 and headquartered in Ramallah. It serves the Palestinian healthcare market and is listed on the Palestine Exchange (PEX:BPC) with 251-500 employees.
- Ownership category
- akta.pro rank
Birzeit Pharmaceutical industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Small-Molecule Generics (Branded/Unbranded) (HLAIABAA)
- akta.pro secondary industry
- Generic Hospital & Institutional Products (HLAIABAL)
Keywords
Where Birzeit Pharmaceutical is headquartered
LocationHeadquarters
- HQ city
- Ramallah
Markets served
Birzeit Pharmaceutical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Operations, Infrastructure, Technology or R&D
Birzeit Pharmaceutical product offering
Product offeringCore offering
Birzeit Pharmaceutical is a manufacturer of generic medicines and pharmaceutical products. The company produces finished generic drug formulations for the Palestinian and regional healthcare market, operating as a physical-goods manufacturer rather than a software, platform, or pure-service provider. Founded in 1937 and headquartered in Ramallah, it is publicly listed on the Palestine Exchange (pex:BPC).
Product overview
No product or service information available. The source displays a loading/verification page with no accessible content.
Differentiator
Problem solved
Functional benefit
Products and services
- Generic pharmaceutical products Generic medicines and pharmaceutical products manufactured by Birzeit Pharmaceutical for the healthcare market. Sold to pharmaceutical distributors, pharmacy chains, hospitals, clinics, and public-sector health buyers.
Companies that use Birzeit Pharmaceutical
Customer profileIdeal customer profiles2 records
Birzeit Pharmaceutical technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Birzeit Pharmaceutical partnerships and signals
Strategic signalRecent moves2 records
Expansion highlights1 record
Birzeit Pharmaceutical competitors and assessment
Company assessmentDirect peers
- Jazeera Pharmaceutical Industries (JPI): JPI is a Saudi Arabian generic pharmaceutical manufacturer producing tablets, capsules, syrups, and injectables for local and regional markets. Its focus on affordable generics for the MENA region mirrors Birzeit's positioning.
- Tabuk Pharmaceuticals: Tabuk is a Saudi pharmaceutical company manufacturing generics, branded generics, and biosimilars primarily for MENA markets. Overlaps with Birzeit in generic small-molecule manufacturing and regional customer base.
- Gulf Pharmaceutical Industries (Julphar): Julphar is a UAE-based generic pharmaceutical manufacturer with a large MENA and emerging-markets footprint. It competes with Birzeit for regional generic tenders and offers a comparable product mix of small-molecule generics.
- Pharco Pharmaceuticals: Pharco is a leading Egyptian generic pharmaceutical manufacturer with significant MENA and African market presence. Overlaps with Birzeit as a regional generic manufacturer focused on affordable essential medicines.
- SPIMACO Addwaeih: SPIMACO is one of the largest Saudi generic pharmaceutical manufacturers, producing a wide range of dosage forms for regional and export markets. Comparable to Birzeit as a regional generic manufacturer competing for similar public-sector tenders.
- EIPICO (Egyptian International Pharmaceutical Industries): EIPICO is one of the largest Egyptian generic pharmaceutical manufacturers, producing a broad range of dosage forms for domestic and export markets across the Arab world. Comparable business model and regional target markets to Birzeit.
- Hikma Pharmaceuticals: Hikma is a Jordan-headquartered generic and specialty pharmaceutical manufacturer with a broad MENA and US footprint. It is the closest regional peer to Birzeit in terms of business model (generic small molecules) and target markets (Arab-world public and private healthcare procurement).
Broad incumbents
- Cipla: Cipla is a major Indian-headquartered generic pharmaceutical manufacturer with a strong presence across Africa, the Middle East, and other emerging markets. Comparable as a globally scaled supplier of affordable generics to developing-market healthcare systems.
- Teva Pharmaceutical Industries: Teva is the world's largest generic pharmaceutical manufacturer and is regionally relevant as an Israeli-headquartered incumbent with deep ties to the local pharmaceutical market. It represents the dominant incumbent competitive threat in the same geographic area as Birzeit.
- Aspen Pharmacare: Aspen is a large South African-headquartered generic and specialty pharmaceutical manufacturer with global emerging-markets reach. Comparable as a scaled generic manufacturer competing in similar price-sensitive public-procurement markets.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat3 records
Key risks4 records
Key highlights4 records
Customer concentration
Birzeit Pharmaceutical social profiles
Digital presenceBirzeit Pharmaceutical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Birzeit Pharmaceutical leadership team
Management profileNumber of profiles
Birzeit Pharmaceutical funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Birzeit Pharmaceutical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Birzeit Pharmaceutical
What does Birzeit Pharmaceutical do?
Birzeit Pharmaceutical is a manufacturer of generic medicines and pharmaceutical products. The company produces finished generic drug formulations for the Palestinian and regional healthcare market, operating as a physical-goods manufacturer rather than a software, platform, or pure-service provider. Founded in 1937 and headquartered in Ramallah, it is publicly listed on the Palestine Exchange (pex:BPC).
When was Birzeit Pharmaceutical founded?
Birzeit Pharmaceutical was founded in 1937. It employs 251 to 500 people.
Where is Birzeit Pharmaceutical based?
Birzeit Pharmaceutical is headquartered in Ramallah.
Who are Birzeit Pharmaceutical's main competitors?
Direct peers on record are Jazeera Pharmaceutical Industries (JPI), Tabuk Pharmaceuticals, Gulf Pharmaceutical Industries (Julphar), Pharco Pharmaceuticals, SPIMACO Addwaeih, EIPICO (Egyptian International Pharmaceutical Industries) and Hikma Pharmaceuticals. Broad incumbents are Cipla, Teva Pharmaceutical Industries and Aspen Pharmacare.
Does Birzeit Pharmaceutical have an API?
No public API is recorded for Birzeit Pharmaceutical.
What industry is Birzeit Pharmaceutical in?
Birzeit Pharmaceutical's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAA, Small-Molecule Generics (Branded/Unbranded), with a secondary code of HLAIABAL, Generic Hospital & Institutional Products. Its NAICS code is 325412 and its SIC code is 2834.